Last reviewed · How we verify
NCT07020078
Oral Health Condition Among a Group of Ionizing Radiation Field Workers
trial testing Salivary redox biomarkers in Salivary Redox Biomarkers and Oral Health in 90 participants. Not yet recruiting.
25 July 2025
Quick facts
| Lead sponsor | Al-Mustansiriyah University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 90 |
| Start date | 25 June 2025 |
| Primary completion | 25 July 2025 |
| Estimated completion | 25 August 2025 |
Drugs / interventions tested
- Salivary redox biomarkers
Conditions studied
- Salivary Redox Biomarkers and Oral Health — all drugs for Salivary Redox Biomarkers and Oral Health →
Sponsor
Al-Mustansiriyah University
Who can join
Adults 30 to 40, male only, with Salivary Redox Biomarkers and Oral Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to test the effect of ionizing radiation on salivary Redox status among a group of ionizing radiation workers by measuring salivary biomarkers(malondialdehyde,8\_hydroxy\_deoxyguanosine and catalase) and measuring oral health condition by plaque index. 90 male subjects will be enrolled in this study between 30\_40 years old worked in Baghdad teaching hospital ,30 subjects exposed from computed tomography department ,30 subjects exposed from x\_ray department and 30 subjects unexposed from laboratory department in the same hospitals. The method of the study is taking unstimulated saliva sample from the subjects and oral health measure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07020078
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Al-Mustansiriyah University trials
Trials by the same sponsor.
- NCT07375004 — Injectable PRF in Non-Surgical Periodontal Treatment · NA · active not recruiting
- NCT06921434 — the Effect of Monk Fruit and Splenda on Salivary Ph and Streptococcus Mutans Count in Vivo Study · NA · not yet recruiting
- NCT07182526 — Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycys · Phase 2 · recruiting
- NCT07493291 — Effectiveness and Safety of Palbociclib: Brand vs. Generic in Iraqi Stage IV Breast Cancer Patients · active not recruiting
- NCT07133659 — Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot S · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07020078 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Al-Mustansiriyah University
- Last refreshed: 13 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07020078.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing